跳至主要内容
临床试验/CTRI/2019/02/017408
CTRI/2019/02/017408尚未招募未知

Assessing Trop2 expression and its correlation with the anti-Trop2 immune status in ovarian cancer patients

ICMR National Institute for Research in Reproductive Health0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1.Group A - Women with epithelial ovarian carcinoma as determined by histopathology/cytology aged 18-75 years
  • 2.Group B - Age-matched healthy women with no reported symptoms gynecological problem (e.g. Ovarian cysts, uterine fibroids, RTI etc.)
  • 3.Group C- Women with cervical disorder with morphologically normal ovaries undergoing hysterectomy along with oophorectomy

排除标准

  • 1.Group A- Non-epithelial ovarian carcinoma patients, Ovarian carcinoma patient coming with a recurrence, Patients with secondary ovarian carcinoma. Retrovirus infected patients and patients taking steroids for other disorders.
  • 2.Group C- Cystic ovaries or ovaries with benign growth or any other significant abnormality, women with uterine endometrial disorders. Women with autoimmune disorder

研究者

发起方
ICMR National Institute for Research in Reproductive Health

相似试验